A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer (Q79372143)
Jump to navigation
Jump to search
scientific article published on 20 November 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer |
scientific article published on 20 November 2006 |
Statements
A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer (English)
Robert Coleman
Alessandro Minisini
Anne Hamilton
Matti Aapro
Patrick Therasse
Giuseppe Mottino
Jan Bogaerts
Martine Piccart
20 November 2006